Lv3
326 积分 2025-12-29 加入
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
1天前
待确认
Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
6天前
已完结
《成人特发性肺纤维化(更新)和进展性肺纤维化：ATS/ERS/JRS/ALAT临床实践指南(2022版)》解读(一)：进展性肺纤维化识别与治疗
7天前
已完结
《成人特发性肺纤维化(更新)和进展性肺纤维化：ATS/ERS/JRS/ALAT临床实践指南(2022版)》解读(二)：特发性肺纤维化的诊断与治疗
7天前
已完结
A Narrative Review of Biologic Therapies for Type 2 Inflammation in Severe Asthma and Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): Mechanisms, Efficacy, and Safety
16天前
已完结
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
16天前
已完结
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
18天前
已完结
Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial
18天前
已完结
Oxygen saturation thresholds in children with acute respiratory distress (OxyKids): a multicentre, open, parallel-group, randomised clinical trial
21天前
已完结
皖公网安备34019202002308
